- Report
- August 2025
- 140 Pages
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- August 2025
- 101 Pages
Global
From €2658EUR$2,950USD£2,279GBP
- Report
- July 2025
- 150 Pages
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- July 2025
- 155 Pages
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- July 2025
- 170 Pages
Global
From €4370EUR$4,850USD£3,747GBP
- Report
- June 2025
- 92 Pages
Europe
From €3559EUR$3,950USD£3,052GBP
- Report
- June 2025
- 101 Pages
Global
From €3109EUR$3,450USD£2,666GBP
- Report
- June 2025
- 128 Pages
Canada
From €5402EUR$5,995USD£4,632GBP
- Report
- June 2025
- 126 Pages
Australia
From €5402EUR$5,995USD£4,632GBP
- Report
- June 2025
- 123 Pages
India
From €5402EUR$5,995USD£4,632GBP
- Report
- June 2025
- 134 Pages
South Korea
From €5402EUR$5,995USD£4,632GBP
- Report
- June 2025
- 123 Pages
Italy
From €5402EUR$5,995USD£4,632GBP
- Report
- June 2025
- 126 Pages
Germany
From €5402EUR$5,995USD£4,632GBP
- Report
- June 2025
- 126 Pages
France
From €5402EUR$5,995USD£4,632GBP
- Report
- June 2025
- 122 Pages
United Kingdom
From €5402EUR$5,995USD£4,632GBP
- Report
- June 2025
- 182 Pages
United States
From €5402EUR$5,995USD£4,632GBP
- Report
- June 2025
- 140 Pages
Japan
From €1379EUR$1,530USD£1,182GBP
€1622EUR$1,800USD£1,391GBP
- Report
- May 2025
- 191 Pages
Global
From €4460EUR$4,950USD£3,825GBP
- Report
- May 2025
- 102 Pages
Global
From €2658EUR$2,950USD£2,279GBP
- Report
- May 2025
- 76 Pages
Middle East, Africa
From €2658EUR$2,950USD£2,279GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more